Abstract:Jing Lu Shangda Li 1 Haimei Li Tingting Mou Lihong Zhou Bochao Huang Manli Huang Yi Xu 1The Key Laboratory of Mental Disorder Management in Zhejiang Province, Department of Psychiatry, First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang University Brain Research Institute, Hangzhou, Zhejiang Province, People’s Republic of China; 2Institute of Criminal Science and Technology, Hangzhou Public Security Bureau, Hangzhou, Zhejiang Province, People’s Republic of China Purpose: There is growing evidence showing that inflammatory cytokines and neuropeptides may be involved in the pathophysiology of suicidal behavior. However, studies have yielded contradictory data, and no biological markers that help predict suicide have been identified. This study aimed to identify biological patterns, such as NPY, IL-1β and hypocretin plasma levels, in people who died by suicide. Patients and methods: Twenty-two people who died by suicide compared with 22 controls matched for age and sex were studied. In suicide and control subjects, we estimated the levels of NPY, IL-1β and hypocretin in plasma using enzyme-linked immunosorbent assay. The data are presented as the median (25th–75th percentile). Results: We found (1) a significant elevation in plasma NPY levels in suicide subjects versus control subjects (suicide: 11.38 (9.380–16.55); controls: 8.95 (7.590–10.93); P=0.013), and plasma NPY concentrations were approximately 62% higher in suicide subjects than those in control subjects; (2) a significant decrease in plasma IL-1β concentrations between suicide and control subjects (suicide: 121.1 (82.97–143.0); controls: 425.9 (233.1–835.3); P<0.001) as well as a decrease in IL-1β concentrations by almost 80%; and (3) no significant difference in plasma hypocretin levels between suicide and control subjects (suicide: 16.62 (13.62–25.77); controls: 21.63 (14.97–29.72); P=0.356). Conclusion: Our results suggest that plasma NPY and IL-1β were related with suicide behavior rather than to suicide causes or suicide method. Specific combinations of plasma biomarkers may discriminate between types of suicidal behaviors and indicate increased risk for future suicide attempts.

Prefrontal Alterations in GABAergic and Glutamatergic Gene Expression in Relation to Depression and Suicide.

Ndt_a_219962 2893..2900

Changes in glial gene expression in the prefrontal cortex in relation to major depressive disorder, suicide and psychotic features

Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide

Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide

Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients.

Different stress-related gene expression in depression and suicide

Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity

Integrative transcriptome- and DNA methylation analysis of brain tissue from the temporal pole in suicide decedents and their controls

Integrative analyses of scRNA-seq, bulk mRNA-seq, and DNA methylation profiling in depressed suicide brain tissues

Brain transcriptomic signatures for mood disorders and suicide phenotypes: an anterior insula and subgenual ACC network postmortem study

Network-based approach to identify molecular signatures in the brains of depressed suicides

Second-trimester Exposure to Maternal Stress is a Possible Risk Factor for Psychotic Illness in the Child

Altered transcriptomes, cell type proportions, and dendritic spine morphology in hippocampus of suicide decedents

Transcriptomics and sequencing analysis of gene expression profiling for major depressive disorder

Genome-wide methylome-based molecular pathologies associated with depression and suicide

A Unique Gene Expression Signature Associated with Serotonin 2C Receptor RNA Editing in the Prefrontal Cortex and Altered in Suicide.

Glial Markers of Suicidal Behavior in the Human Brain—A Systematic Review of Postmortem Studies

Abnormal Baseline Brain Activity in Suicidal and Non-Suicidal Patients with Major Depressive Disorder

Peripheral Metabolic Abnormalities of Lipids and Amino Acids Implicated in Increased Risk of Suicidal Behavior in Major Depressive Disorder

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.